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Abstract
Background: Subtle effects of vitamin D deficiency on behavior have been suggested. We investigated the
association of vitamin D status with mental health and violence behaviors in a sample of Iranian adolescents.
Methods: This nationwide study was conducted in 2009–2010 in 1095 Iranian school students with mean age
14.7 ± 2.6 years. Items were adapted from the Global School-based Student Health Survey (GSHS). Psychiatric
distress was considered as the self-reported anger, anxiety, poor quality sleep, confusion, sadness/depression, worry,
and violence-related behaviors (physical fight, having bully, or getting bullied).
Results: Forty percent had serum 25(OH)D values below 10 ng/mL (vitamin D deficient), and 39 % had levels
10-30 ng/mL (vitamin D insufficient). The prevalence of self-reported anger, anxiety, poor quality sleep, sadness/
depression, and worry was significantly lower (P < 0.05) in vitamin D sufficient participants compared with their
other counterparts. The odds of reporting anger, anxiety, poor quality sleep, and worry, increased approximately
1.5 to 1.8 times in vitamin D insufficient compared with normal children and adolescents (P < 0.05). Risk estimates
indicated that vitamin D insufficient and deficient subjects had higher odds of reporting worry compared to normal
vitamin D group [OR = 2.417 (95 % CI: 1.483-3.940) for vitamin D insufficient students, and OR = 2.209 (95 % CI:
1.351-3.611) for vitamin D deficient students] (P-trend = 0.001). Violence behaviors did not show any association
with vitamin D status (P > 0.05).
Conclusion: Some psychiatric distress such as anger, anxiety, poor quality sleep, depression, and worry are
associated with hypovitaminosis D in adolescents. The clinical significance of the current findings should be
determined in future longitudinal studies.
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Introduction
Mental disorders are one of the most common health
problems worldwide. About half of all mental disorders
begin before the age of 14 [1]. The World Health
Organization (WHO) predicts that by the year 2020,
childhood neuropsychiatric disorders will rise to become
one of the five most common causes of mortality, mor-
bidity, and disability among children [2].
Studies in various countries including Egypt, Nigeria,
India, Indonesia, Thailand, and Sri Lanka [3] have shown
that rates of child and adolescent mental disorders are
comparable to rates reported in developed countries [4].
Iran, as a developing country, is undergoing significant
social, cultural, and economic changes, which affect its
populations' mental health status.
Few studies have been conducted to evaluate mental
health status in children and adolescents in Iran. Two
surveys with similar methodology in Tehran have shown
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the prevalence of overall psychological disorders to be
17.9 % in 7-12-year old children [5] and 14.2 % in 12–17
year-old adolescents [6]. A systematic review of studies
conducted among high school students in Iran showed
that the prevalence rates of mental disorders were re-
ported in a wide range from 4.34 % to 16.6 % in studies
using diagnostic instruments to 34.4 % in studies using
screening instruments [7].
Vitamin D is a hormone with key functions more than
calcium homeostasis and maintaining bone health. Vita-
min D receptors are present in a wide variety of cells, in-
cluding neurons and glial cells. Genes encoding the
enzymes involved in the metabolism of vitamin D are
also expressed in the brain [8]. Vitamin D promotes
neurogenesis and regulates the synthesis of neurotrophic
factors, which support differentiation of neurons and
survival [9, 10].
Most epidemiological evidence supports a link be-
tween vitamin D deficiency and mental disorders in
adults. A recent British study showed that low levels of
vitamin D3 are associated with increased risk of common
mental disorders in mid-adulthood [11]. Low serum 25-
hydroxyvitamin D [25(OH)D] has been also associated
with increased odds of cognitive impairment [12–14]
and depressive symptoms in adults [15–17], but some
inconsistencies exist between different studies [18–21].
The purpose of this study was to investigate the asso-
ciation of vitamin D deficiency with psychiatric distress
and violence behaviors in a nationally representative
sample of Iranian children and adolescents.
Materials and methods
The data used in this study were obtained as part of the
third national survey of school student high risk be-
haviors (2009–2010) in Iran entitled “Childhood and
Adolescence Surveillance and PreventIon of Adult Non-
communicable Disease” (CASPIAN) study.
Details on the survey design and methods have been
explained previously [22]. In brief, 5570 school students
aged 10–18 years, living in urban and rural areas in 27
provinces of Iran were selected via multistage-random
cluster sampling method. Eligible schools in this survey
were stratified according to the information bank of the
Ministry of Health and Medical Education and then,
they were selected randomly. In selected schools, the
students were selected via random sampling method.
Ethical committees and relevant national organizations
approved the study. Oral assent was obtained from stu-
dents, and written informed consent from their parents.
A team of trained health care professionals checked the
performance of the personnel, monitored and calibrated
equipment according to standard protocols.
As described before, the current study was performed
in a sub-sample randomly selected among participants
in the main study. It was approved by the Research Eth-
ics Committee of Isfahan University of Medical Sciences,
Isfahan, Iran. The sample size of the current study was
calculated by assuming an alpha error of 5 % and a
power of 80 % and design effect of 1.25, while adding
25 % to the estimated sample size. The final sample size
was calculated as 1000, and for possible missing data, we
increased it by 10 % and studied 1100 samples [23].
Clinical and laboratory measurements
Weight was measured on calibrated scales to the nearest
0.1 kg while subjects wearing light clothing, and height
were measured without shoes to the nearest 0.1 cm.
Body mass index (BMI) was calculated as weight (kg) di-
vided by height squared (m2). Waist circumference was
measured using a non-elastic tape at a point midway be-
tween the lower border of the rib cage and the iliac crest
at the end of normal expiration to the nearest 0.1 cm.
Blood samples were collected in the morning after
10–12 h overnight fasting. Serum concentration of
25(OH)D was analyzed quantitatively by direct com-
petitive immunoassay chemiluminescene method using
LIASON® 25 OH vitamin D assay TOTAL (DiaSorin,
Inc.), with a coefficient of variation (CV) of 9.8 %. Serum
25(OH)D level of less than 10 ng/mL was considered as
vitamin D deficiency and levels between 10-30 ng/mL as
vitamin D insufficiency [24].
Demographic information was completed by obtain-
ing data for all officially enrolled students in the sam-
pled classes from the school record. Demographic and
anthropometric information was collected based on the
Persian version of main questionnaire of the World
Health Organization- Global School-based student
Health Survey (WHO-GSHS).
Parental level of education, possessing a family private
car and type of home, physical activity, sedentary life-
style, birth weight, breast feeding duration, type of milk
and type of complementary feeding in childhood were
assessed through two sets of questionnaires for students
and parents which were filled in under the supervision
of the trained health professionals.
Having personal home, personal car, and personal
computer was used as some components of socio-
economic status. Breastfeeding duration was defined as
the whole month that participants were breast fed (ex-
clusively or in combination with other foods). Comple-
mentary feeding was asked as home-made foods or
commercial baby food. Sedentary behavior was assessed
by watching TV and working computer.
Psychiatric distress and violence variables
In this study, we used part of Global School-based
Student Health Survey (GSHS) questionnaire from
WHO for information regarding psychiatric distress
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and violence behaviors. The validity of questionnaire
has been evaluated in 120 urban and rural students in
one of the regions around Tehran (the Cronbach’s reli-
ability coefficient >0.7) [25].
Psychiatric distress included one of the angriness,
anxiety, insomnia, confusion, sadness/depression, and
worry, which were reported on a Likert scale question-
naire by students. In addition, some questions about
violence and students’ perceived general health status
were asked. All factors were categorized as binary vari-
ables. The questions, codes and categorization have
been shown in Appendix 1.
Statistical analysis
Findings on continuous variables are presented as
means (SD)/median (interquartile range), and categor-
ical data as percentages. Association between qualita-
tive variables was assessed by using Pearson Chi-square
test. The normality of continuous variables was as-
sessed by Kolmogorov-Smirnov test, and due to lack of
normality of serum concentrations of 25(OH)D, the
Mann–Whitney U test was used to compare the me-
dian values of serum25(OH)D across psychiatric dis-
tress categories.
Logistic regression analysis was applied to determine
the association of 25(OH) D status (as continuous and
categorical variable) with psychiatric distress in three
models: Model I, crude model (without adjustment);
Model II, adjustment for age, sex, and living area; and
Model III, additionally adjustment for other potential
confounders, including sleeping hours, socio-economic
status, physical activity, breast feeding, type of comple-
mentary feeding, BMI, and type of milk used in infancy.
The results of logistic regression are shown as odds ra-
tios (OR) and 95 % confidence interval (CI). Data were
analyzed by SPSS statistical software (version 16.0; SPSS
Inc., Chicago, IL, USA); the significance level was set at
P < 0.05.
Results
Among the 1095 children and adolescents included in
the analysis (mean age 14.7 ± 2.6 years; mean BMI
19.3 ± 4.2 kg/m2), the median serum 25(OH)D was
13.0 ng/mL(interquartile range 6.8-27.4 ng/mL). A
total of 40 % were vitamin D deficient and 39 % were
vitamin D insufficient.
Baseline characteristics of subjects according to vita-
min D status (normal, deficient or insufficient) and by
sex are shown in Table 1. Participants with different sta-
tus of vitamin D were comparable in case of anthropo-
metric measurements, duration of breast- feeding, type
of milk used in infancy, birth weight, physical activity or
sedentary behavior, and socio-economic status. The only
significant difference was documented for the type of
complementary feeding in childhood among normal,
vitamin D deficient and vitamin D insufficient girls (P-
trend = 0.022) (Table 1).
Table 2 represents the prevalence of psychosocial dis-
orders according to the vitamin D status (normal, defi-
cient or insufficient) in boys and girls. The prevalence of
self-reported angriness, anxiety, poor quality sleep,
sadness/depression, and worry was significantly lower in
vitamin D sufficient subjects compared with their other
counterparts (P <0.05).
Table 3 shows that median levels of serum 25(OH) D
were not significantly different in boys who experienced
angriness during the prior 6 months compared with
other boys (P > 0.05). However, median levels of vitamin
D was significantly lower in boys who reported to have
poor quality sleep, sadness/depression, or worry com-
pared with those who did not (P < 0.05). In girls, the
serum levels of 25(OH)D was lower in those who
reported angriness or anxiety during the previous
6 months, or sadness/depression or worry during the
previous 12 months compared with those who did not
report them (P < 0.05). In total, participants who re-
ported angriness, anxiety, poor quality sleep, sadness/de-
pression, or worry, had lower levels of serum 25(OH)D
than those who did not report such disorders (P < 0.05).
These differences in serum 25 (OH) D levels were highly
significant in reporting worry (10.1 ng/mL [interquartile
range: 4.2 - 19.7] in individuals who reported worry, com-
pared with 15.0 ng/mL [interquartile range: 7.7 - 29.2] in
those without worry) (P < 0.001).
Table 4 presents the association parameters (OR and
95 % CI) of vitamin D status with psychiatric distress
and violence from logistic regression models. In model I,
the odds of angriness increased 1.56 times in vitamin D
insufficient individuals compared with their other coun-
terparts. In vitamin D deficient subjects, the odds ratio
was 1.80 times higher than vitamin D sufficient students
(P-trend = 0.026). By the inclusion of sex, age, and living
area in model II, and also by additional adjustment for
sleeping hours, socio-economic status, physical activity,
breast feeding, type of milk used in infancy, complemen-
tary feeding and BMI in model III, the associations were
approximately the same as the crude model (P-trend =
0.020 and 0.015; respectively).
Children and adolescents with vitamin D insufficiency
and vitamin D deficiency were 1.61 and 1.81 times more
likely to report anxiety disorders compared with their
other counterparts in model I (P-trend = 0.013). These
association were stronger in model II (P = 0.009), but the
same as the crude model in model III (P-trend = 0.015).
Similar associations were observed in reporting anxiety,
poor quality sleep, and worry, for which subjects with
vitamin D insufficiency and vitamin D deficiency were
approximately 1.5 to 1.8 times more likely to report such
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Table 1 General characteristics of participants according to vitamin D status categories: the CASPIAN-III Study
Variables Vitamin D status (boys) N = 568 P-valuea Vitamin D status (girls) N = 527 P-valuea Vitamin D status (total) N = 1095 P-valuea
Deficient Insufficient Normal Total Deficient Insufficient Normal Total Deficient Insufficient Normal Total
Age (y) 14.7 ± 2.5 14.6 ± 2.3 14.7 ± 2.7 14.6 ± 2.5 0.870 14.9 ± 2.7 14.9 ± 2.7 14.8 ± 2.8 14.9 ± 2.7 0.950 14.8 ± 2.6 14.7 ± 2.6 14.7 ± 2.7 14.7 ± 2.6 0.803
Weight (kg) 46.9 ± 22.6 45.6 ± 13.9 45.6 ± 13.4 46.2 ± 17.9 0.665 47.8 ± 16.9 47.9 ± 18.8 48.7 ± 18.9 48.0 ± 18.0 0.915 47.4 ± 20.1 46.7 ± 16.6 47.0 ± 16.1 47.0 ± 17.9 0.726




66.2 ± 9.4 66.0 ± 11.2 67.4 ± 10.2 66.4 ± 10.3 0.443 68.4 ± 13.3 70.4 ± 15.6 69.2 ± 11.4 69.4 ± 13.9 0.351 67.2 ± 11.4 68.2 ± 13.7 68.2 ± 10.8 67.8 ± 12.2 0.260




16.70 ± 8.0 16.4 ± 8.0 15.6 ± 8.2 16.3 ± 8.1 0.482 15.3 ± 8.1 16.5 ± 7.5 16.1 ± 8.8 15.9 ± 8.0 0.324 16.03 ± 8.1 16.43 ± 7.7 15.82 ± 8.5 16.1 ± 8.0 0.636
Type of milk used in infancy
Breast fed 83.5 85.8 75.4 82.5 77.3 85.5 79.0 81.0 80.6 85.7 77.0 81.8
Formula 4.5 4.4 8.2 5.3 0.178 3.9 2.3 5.0 3.5 0.245 4.2 3.3 6.8 4.4 0.053
Mixed 12.1 9.8 16.4 12.2 18.7 12.1 16.0 15.5 15.2 11.0 16.2 13.8
















8.0 5.3 4.8 6.3 8.5 4.2 3.0 5.6 8.2 4.7 4.0 6.0
Birth weight (g)
<2500 15.1 17.9 16.1 16.4 16.3 11.1 16.2 14.1 15.6 14.4 16.1 15.3
2500-4000 74.9 76.4 76.6 75.8 0.525 75.9 77.4 72.7 75.9 0.399 75.4 77.0 74.9 75.9 0.973
>4000 10.0 5.6 7.3 7.8 7.9 11.5 11.1 10.0 9.0 8.7 9.0 8.9
Watching TV (%)
<2 h 49.1 53.8 53.5 51.9 0.562 50.7 51.0 45.5 49.8 0.633 49.9 52.5 50.0 50.9 0.708
















Table 1 General characteristics of participants according to vitamin D status categories: the CASPIAN-III Study (Continued)
Working with computer (%)
<2 h 91.0 94.6 96.0 93.5 0.137 88.6 86.7 84.7 87.1 0.634 89.9 90.7 91.1 89.9 0.864
>2 h 9.0 5.4 4.0 6.5 11.4 13.3 15.3 12.9 10.1 9.3 8.9 9.6
Father’s education (%)
Illiterate 11.0 13.9 15.7 13.2 17.1 16.4 9.9 15.4 13.8 15.1 13.2 14.2
Elementary to
high school
83.3 77.1 81.1 80.5 0.171 72.4 73.4 74.3 73.2 0.330 78.2 75.2 78.1 77.0 0.846
College 5.7 9.0 3.1 6.3 10.6 10.3 15.8 11.5 8.0 9.6 8.8 8.8
Mother’s education (%)
None 20.0 16.5 17.8 18.2 23.8 24.3 15.8 22.5 21.8 20.5 17.0 20.2
Elementary to
high school
77.4 76.7 79.8 77.7 0.148 71.3 71.1 73.3 71.6 0.104 74.5 73.9 77.0 74.8 0.368
College 2.6 6.8 2.3 4.1 5.0 4.6 10.9 6.0 3.7 5.6 6.1 5.0
Socio-economic status (%)
Personal home 85.8 88.2 88.2 87.2 0.699 84.4 81.9 81.8 82.9 0.761 85.1 85.0 85.4 85.2 0.992
Rented home 14.2 11.8 11.8 12.8 15.6 18.1 18.2 17.1 14.9 15.0 14.6 14.8
Personal car (%)
Yes 49.1 50.2 47.2 49.1 0.869 47.8 44.7 55.0 47.9 0.231 48.5 47.5 50.7 48.6 0.744
No 50.9 49.8 52.8 50.9 52.2 55.3 45.0 52.1 51.5 52.5 49.3 51.4
Personal computer (%)
Yes 38.9 44.7 35.7 40.3 0.219 41.3 39.0 49.5 41.9 0.203 40.0 41.9 41.7 41.1 0.829
No 61.1 55.3 64.3 59.7 58.7 61.0 50.5 58.1 60.0 58.1 58.3 58.9
Sleeping
duration (hours)
8.9 ± 2.2 8.9 ± 1.9 9.2 ± 2.3 9.0 ± 2.1 0.358 9.1 ± 2.2 9.2 ± 2.1 8.7 ± 2.2 9.0 ± 2.2 0.137 9.0 ± 2.2 9.1 ± 2.0 9.0 ± 2.3 9.0 ± 2.1 0.908
Physical activity
(hour/week)
2.9 ± 1.5 2.9 ± 1.6 2.9 ± 1.4 2.9 ± 1.5 0.932 3.6 ± 2.4 3.6 ± 1.4 3.6 ± 1.6 3.6 ± 1.9 0.936 3.3 ± 2.0 3.2 ± 1.5 3.2 ± 1.5 3.2 ± 1.7 0.866
Living area (%)
Urban 64.5 67.8 68.2 66.5 0.691 65.5 70.6 65.7 67.7 0.474 65.0 69.1 67.1 67.0 0.440
Rural 35.5 32.2 31.8 33.5 34.5 29.4 34.3 32.3 35.0 30.9 32.9 33.0
Type of dairy used by students
Low-fat 81.9 84.3 82.9 83.0 0.795 87.4 83.3 80.2 84.3 0.249 84.4 83.8 81.7 83.6 0.675
High-fat 18.1 15.7 17.1 17.0 12.6 16.7 19.8 15.7 15.6 16.2 18.3 16.4
a-Comparisons based on χ2 test or independent samples t test, as appropriate
b-It means using home-made foods, but sometimes using commercial baby foods
















Table 2 Prevalence of psychiatric distress according to vitamin D status: the CASPIAN III study
Variables Vitamin D status (boys) N = 568 P-valueb Vitamin D status (girls) N = 527 P-valueb Vitamin D status (total) P-valueb
Deficienta Insufficienta Normala Total Deficienta Insufficienta Normala Total Deficienta Insufficienta Normala Total
Angriness (Yes) % 67.5 74.0 57.4 67.6 0.006 65.2 65.6 53.9 63.2 0.097 66.4 69.6 55.8 65.4 0.002
Anxiety (Yes) % 69.7 71.6 62.8 68.8 0.219 60.9 62.4 43.1 58.1 0.003 65.5 67.0 54.1 63.7 0.003
poor quality sleep(Yes) % 48.9 43.8 35.7 44.0 0.052 46.9 49.1 40.2 46.5 0.329 47.9 46.6 37.7 45.3 0.031
Confusion (Yes) % 35.1 30.8 34.1 33.3 0.618 33.3 36.7 25.5 33.2 0.140 34.2 33.7 30.3 33.2 0.565
Sadness /Depression (Yes) % 32.9 35.2 18.7 30.2 0.021 29.9 25.0 12.5 24.3 0.021 31.4 29.5 16.0 27.2 0.001
Worry (Yes) % 31.4 23.5 18.2 25.7 0.056 27.3 25.3 20.0 25.0 0.493 29.5 24.7 19.0 25.5 0.042
Physical fight (Yes) % 46.1 45.2 39.8 44.3 0.501 58.5 58.4 59.6 58.7 0.979 52.0 51.8 48.5 51.2 0.658
Getting bullied (Yes) % 35.8 28.0 32.0 32.1 0.220 35.4 38.5 39.6 37.5 0.721 35.6 33.5 35.4 34.7 0.786
Bully (Yes) % 19.7 21.7 25.0 21.6 0.512 31.9 35.1 34.7 33.7 0.769 25.5 28.4 29.3 27.4 0.488
General health (bad) % 25.5 25.0 26.1 25.4 0.977 26.4 23.9 23.0 24.7 0.770 25.9 24.4 24.7 25.0 0.873
a-Normal: serum 25(OH)D > 30 ng/mL; Vitamin D insufficient: 10 < 25(OH)D < 30 ng/mL; vitamin D deficient: 25(OH)D < 10 ng/mL
















disorders in comparison to those with normal vitamin D
levels (P < 0.05). The strongest association was observed
in case of reporting sadness/depression, the odds of
which increased approximately 2.2 to 2.5 time in vitamin
D insufficient and deficient compared with their vitamin
D sufficient counterparts (P < 0.01). Other parameters,
as the self-reported general health status and violence
behaviors did not show any association with vitamin D
status (P > 0.05) (Table 4).
According to the logistic regression methods, for every
1 ng/mL increase of serum 25(OH)D levels, the odds of
angriness and anxiety decreased by 1-2 % (P < 0.001),
and the likelihood of poor quality sleep, sadness/depres-
sion, and worry had the same results (P < 0.05) (Table 5).
Discussion
This nationwide study, which to the best of our know-
ledge is the first of its kind in the pediatric age group,
investigated the psychiatric distress, violence, and gen-
eral health in relation to vitamin D status in a nation-
ally -representative sample of Iranian children and
adolescents. The study found significant associations
between vitamin D deficiency and self-reported psychi-
atric distress as angriness, anxiety, poor quality sleep,
sadness/depression, and worry. However, no significant
association existed between vitamin D status and vio-
lence behaviors.
Anxiety, depression, mood disorders, and behavioral
and cognitive disorders are among the most prevalent
mental health problems of children and adolescents [26].
Different methods and tools could be used for screening
and diagnosis of psychiatric distress. In this study, the
questionnaire of GSHS was used to assess the self-
reported mental health status, violence issues, and gen-
eral health of students. The purpose of the GSHS is to
help countries measure and assess behavioral risk factors
and protective factors in 10 key areas that contribute to
morbidity and mortality among children and adults.
The current study revealed significant associations be-
tween vitamin D deficiency and self-reported psychiatric
distress such as angriness, anxiety, poor quality sleep,
sadness/depression, and worry. To our knowledge, there
is no similar study in this age group to compare our re-
sults. However, most studies in adults have documented
that better vitamin D status is associated with better
cognitive function and mental health [12, 27–32], but
not in others [18–21]. One study found an inverse asso-
ciation between dietary vitamin D and depression [33],
and a number of clinical trials have shown positive ef-
fects of vitamin D on mood and depression [31], but no
Table 3 Serum 25(OH)D concentrations (ng/mL) according to various psychiatric distress: the CASPIAN III studya
Variables Boys, n = 568 P-value Girls, n = 527 P-value Total P-valueb
Angriness No 12.3 (6.3, 36.0) 0.323 14.7 (7.5, 29.7) 0.042 13.7 (6.7, 31.8) 0.033
Yes 12.8 (6.7, 25.7) 11.7 (7.2, 24.5) 12.4 (6.9, 25.3)
Anxiety No 14.0 (6.3, 31.9) 0.308 15.5 (7.7, 31.2) 0.004 14.6 (7.3, 31.3) 0.007
Yes 12.4 (6.6, 26.9) 11.7 (6.6, 23.6) 12.2 (6.6, 25.2)
Poor quality sleep No 14.0 (6.8, 30.7) 0.020 13.4 (7.4, 28.3) 0.329 13.6 (6.9, 29.5) 0.016
Yes 11.2 (6.1, 24.1) 13.2 (7.2, 24.6) 11.6 (6.6, 24.5)
Confusion No 12.6 (6.7, 28.2) 0.694 13.6 (7.4, 28.0) 0.258 13.0 (7.1, 28.0) 0.298
Yes 12.9 (6.2, 28.8) 13.0 (7.1, 24.0) 12.9 (6.6, 25.6)
Sadness/ Depression No 13.5 (6.9, 31.5) 0.017 15.4 (8.1, 29.3) 0.001 14.7 (7.5, 30.4) <0.001
Yes 10.4 (5.5, 20.0) 10.1 (5.0, 18.3) 10.2 (5.2, 18.7)
Worry No 14.2 (7.2, 29.9) <0.001 16.0 (8.1, 28.3) <0.001 15.0 (7.7, 29.2) <0.001
Yes 7.5 (4.0, 19.8) 10.2 (4.8, 19.6) 10.1 (4.2, 19.7)
Physical fight No 13.4 (6.4, 29.5) 0.526 13.1 (7.4, 24.6) 0.551 13.2 (6.6, 27.6) 0.926
Yes 11.9 (6.7, 26.1) 13.3 (7.4, 27.7) 12.5 (7.1, 26.9)
Getting bullied No 13.2 (6.8, 28.7) 0.433 13.6 (7.4, 27.0) 0.892 13.4 (7.0, 27.6) 0.615
Yes 11.6 (6.3, 27.4) 13.1 (7.2, 25.8) 12.5 (6.4, 26.5)
Bully No 12.3 (6.4, 28.2) 0.289 13.0 (7.1, 27.2) 0.387 12.7 (6.7, 27.6) 0.171
Yes 14.9 (6.8, 32.1) 16.3 (7.5, 26.0) 15.5(7.4, 27.3)
General health Good 12.3 (6.6, 26.8) 0.608 13.7 (7.5, 27.3) 0.268 13.3 (6.9, 27.1) 0.695
Bad 13.2 (6.6, 27.9) 11.0 (6.8, 24.0) 11.7 (6.6, 25.9)
aData are median (interquartile range)
bMan-WhitneyUtest
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Table 4 Odds ratios (95 % CI) for psychiatric distress according to vitamin D status: the CASPIAN-III study
Vitamin D status P-trendb
Normala Insufficienta Deficienta
Angriness
Model Ic 1 1.565 (1.129, 2.170) 1.806 (1.297, 2.517) 0.026
Model IId 1 1.577 (1.134, 2.192) 1.868 (1.336, 2.612) 0.020
Model IIIe 1 1.759 (1.185, 2.612) 2.026 (1.365, 3.008) 0.015
Anxiety
Model I 1 1.612 (1.164, 2.231) 1.720 (1.239, 2.388) 0.013
Model II 1 1.655 (1.187, 2.308) 1.815 (1.297, 2.540) 0.009
Model III 1 1.728 (1.162, 2.570) 1.756 (1.185, 2.603) 0.015
poor quality sleep
Model I 1 1.525 (1.101, 2.111) 1.445 (1.042, 2.004) 0.019
Model II 1 1.526 (1.102, 2.114) 1.426 (1.027, 1.979) 0.021
Model III 1 1.348 (0.917, 1.982) 1.472 (1.004, 2.157) 0.258
Confusion
Model I 1 1.198 (0.850, 1.688) 1.170 (0.829, 1.652) 0.341
Model II 1 1.208 (0.856, 1.704) 1.170 (0.828, 1.654) 0.361
Model III 1 1.053 (0.700, 1.585) 1.012 (0.674, 1.520) 0.849
Sadness/Depression
Model I 1 2.417 (1.483, 3.940) 2.209 (1.351, 3.611) 0.001
Model II 1 2.458 (1.504, 4.018) 2.308 (1.407, 3.785) 0.001
Model III 1 2.355 (1.325, 4.187) 2.405 (1.356, 4.267) 0.009
Worry
Model I 1 1.786 (1.126, 2.833) 1.400 (0.873, 2.245) 0.012
Model II 1 1.808 (1.136, 2.878) 1.381 (0.858, 2.224) 0.010
Model III 1 1.484 (0.860, 2.559) 1.246 (0.718, 2.163) 0.149
Physical fight
Model I 1 1.151 (0.834, 1.587) 1.142 (0.827, 1.577) 0.440
Model II 1 1.135 (0.820, 1.571) 1.101 (0.794, 1.527) 0.516
Model III 1 1.282 (0.871, 1.887) 1.358 (0.925, 1.992) 0.312
Getting bullied
Model I 1 1.011 (0.724, 1.413) 0.920 (0.656, 1.290) 0.839
Model II 1 1.015 (0.724, 1.423) 0.896 (0.637, 1.262) 0.919
Model III 1 1.021 (0.680, 1.531) 0.920 (0.614, 1.378) 0.949
Bully
Model I 1 0.826 (0.578, 1.181) 0.961 (0.673, 1.371) 0.256
Model II 1 0.812 (0.565, 1.166) 0.922 (0.643, 1.323) 0.185
Model III 1 0.781 (0.512, 1.189) 0.717 (0.471, 1.091) 0.286
General health
Model I 1 0.936 (0.640, 1.368) 1.014 (0.691, 1.487) 0.676
Model II 1 0.934 (0.638, 1.368) 1.018 (0.693, 1.496) 0.726
Model III 1 1.003 (0.638, 1.577) 1.075 (0.687, 1.684) 0.973
a-Normal: serum 25(OH)D > 30 ng/mL; Vitamin D insufficient: 10 < 25(OH)D < 30 ng/mL; vitamin D deficient: 25(OH)D < 10 ng/mL
b-P-trends resulted from logistic regression
c-Without adjustment (crude models)
d-Adjusted for age, sex, and living area
e-Additionally adjusted for other characteristics including sleeping hours, socio-economic status, physical activity, breast feeding, complementary feeding, BMI, type of milk
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effect of an annual high dose of vitamin D was observed
on depressive symptoms in older women [34]. Pan et al.
also reported no significant correlation between vitamin
D status and depression in Chinese adults [18].
It is very difficult to find whether the differences be-
tween these studies are due to physiological differences
or resulting from methodological aspects as study popu-
lation, method of assessing psychiatric distress, timing of
the blood collection, method of vitamin D assessment,
and covariates considered in regression models.
The current study could adjust the associations for a
range of variables including physical activity-related vari-
ables, sleeping duration, socio-economic status, breast
feeding, type of milk used in infancy, type of comple-
mentary feeding, BMI, and waist circumference. In the
only prospective study, which examined the association
of 25(OH)D3 with depressive symptoms in children, the
association only emerged with symptoms measured
3 years after exposure assessment, and was not present
when symptoms were assessed just 1 year after exposure
assessment. The causality was not confirmed, and the
association was partly explained by factors other than
25(OH)D3 (such as outdoor physical activity) but that
were associated with it and accumulated over time [35].
The mechanism through which vitamin D plays a role
in mental health is not fully understood. Vitamin D is a
neuro-steroid hormone which regulates the metabolism
of neurotransmitters in the central nervous system [36,
37]. The function of monoamine neurotransmitters such
as serotonin and norepinephrine have been known on
pathophysiology of depression and mood disorders [38].
In addition, serotonin regulates stress, anger, depression,
aggression, appetite, and behavior. As a result, the associ-
ation between vitamin D and psychiatric distress might be
mediated by serotonin levels. Some other mechanisms
have been also proposed for the potentially influence of
vitamin D on brain function. Vitamin D receptors (VDRs),
25(OH)D 1-α-hydroxylase, and the cytochrome P-450 that
catalyzes the hydroxylation of calcidiol to the active form
of vitamin D (calcitriol) have been found throughout the
central nervous system [39].
The finding of the considerably high prevalence of
vitamin D deficiency (40 %) and insufficiency (39 %) in
Iranian students is in line with the work of other groups
in Iran demonstrating 78 % vitamin D deficiency (serum
25(OH)D < 20 ng/mL) in children and adolescents aged
8–18 years from Tehran [40], and 91.7 % in similar
population during autumn and winter [41]. The results
necessitate interventions for vitamin D supplementation
or vitamin D fortifications in Iran.
The main limitation of this study is its cross-sectional
design which does not demonstrate the causality of asso-
ciation between psychiatric distress and vitamin D defi-
ciency. A reverse causation could be even assumed;
meaning that psychiatric distress resulted in less outdoor
activity and hence reduced vitamin 25(OH)D concentra-
tions. However, outdoor physical activity and sedentary
behaviors such as watching TV, working with computer,
and sleeping duration were similar in vitamin D deficient
and vitamin D sufficient children. Strengths of our study
include its novelty in the pediatric age group, the large
sample size and generalizability.
At present time, it is premature to conclude that vita-
min D deficiency is related to occurrence of psychiatric
distress in children. Until results of prospective studies
confirm the causality, it is hard to recommend vitamin
D supplementation in adolescents with mental prob-
lems. However, as low levels of 25(OH) D have been
Table 5 Association of 25(OH)D concentrations with psychiatric distress: the CASPIAN III study (N = 1095)
25(OH)D concentrations (ng/mL)
Model Ia P value Model IIb P value Model IIIc P value
Odds ratio (95 % CI) Odds ratio (95 % CI) Odds ratio (95 % CI)
Angriness 0.985 (0.978, 0.992) <0.001 0.984 (0.977, 0.992) <0.001 0.981 (0.972, 0.990) <0.001
Anxiety 0.983 (0.976, 0.991) <0.001 0.982 (0.974, 0.989) <0.001 0.981 (0.973, 0.990) <0.001
Poor quality sleep 0.988 (0.981, 0.996) 0.003 0.988 (0.981, 0.996) 0.002 0.992 (0.983, 1.001) 0.066
Confusion 0.996 (0.988, 1.004) 0.304 0.996 (0.988, 1.004) 0.285 0.999 (0.990, 1.008) 0.860
Sadness/Depression 0.989 (0.979, 0.999) 0.037 0.989 (0.979, 0.999) 0.031 0.990 (0.978, 1.001) 0.083
Worry 0.982 (0.970, 0.993) 0.001 0.982 (0.971, 0.994) 0.002 0.986 (0.973, 0.999) 0.033
Physical fight 0.997 (0.990, 1.005) 0.499 0.998 (0.991, 1.006) 0.632 0.996 (0.987, 1.005) 0.357
Getting bullied 0.998 (0.991, 1.006) 0.664 0.999 (0.991, 1.007) 0.751 0.999 (0.989, 1.008) 0.760
Bully 1.004 (0.996, 1.012) 0.317 1.005 (0.997, 1.013) 0.243 1.004 (0.995, 1.014) 0.365
General health 0.997 (0.989, 1.006) 0.559 0.998 (0.989, 1.006) 0.611 0.997 (0.987, 1.007) 0.602
a-Without adjustment (crude model)
b-Adjusted for age, sex, and living area
c-Additionally adjusted for other characteristics including sleeping hours, socio-economic status, physical activity, breast feeding, type of complementary feeding,
BMI, type of milk used in infancy
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documented in several studies in Iran, prevention and
control of vitamin D deficiency could be suggested as a
health priority. Future studies could determine if vita-
min D supplementation might reduce psychiatric dis-
tress by increasing 25(OH) D levels.
Appendix 1
The questions and codes to categorize students for
psychiatric distress and violence behaviors:
“During the past 6 months, how often did you experi-
ence angriness/anxiety/poor quality sleep/confusion so
that you cannot do your daily activity?” (Response op-
tions were: almost every day, more than once a week, al-
most every week, and almost every month, rarely or
never).
(Almost every day, more than once a week, almost
every week [yes]; almost every month, rarely or never
[no]).
Sadness/Depression: “During the past 12 months, did
you ever feel so sad or hopeless almost every day for
2 weeks or more in a row that you stopped doing your
usual activities?” (Response options were: yes, no).
Worry: “During the past 12 months, how often have
you been so worried about something that you could
not sleep at night?” (Response options were: never,
rarely, sometimes, most of the time, and always) (never,
rarely, sometimes [no]; most of the time, and always
[yes]).
Violence behavior section included physical fight,
bully, or getting bullied as below:
“During the past 12 months, how many times you had
physical fight?” (Response options were: none, 1 time, 2
times, 3 times, 4 times) (none[No], 1 or 2 or 3 or 4 times
[Yes]).
“During the past 3 months, how many times you were
bullied, or got bullied?”(Response options were: none, 1–
2 times, 2–3 times, 4 times or more).(none [No]; 1–2
times, 2–3 times, 4 times or more[Yes])
Self- perceived general health status was assessed as
below:
“In general, would you say your health is:” (Response op-
tions were: excellent, good, fair, poor) (excellent or good
[good status]; fair or poor [bad status]).
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